Vascular endothelial growth factor gene polymorphisms and myocardial infarction

Cardiology

Volumn 114, Issue 1, 2009, Pages 8-10

  Petrovi, Daniel ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ACUTE HEART INFARCTION; ANGIOGENESIS; DISEASE PREDISPOSITION; DNA FINGERPRINTING; GENETIC RISK; GENOTYPE; HEART FAILURE; HUMAN; NOTE; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

GENETIC MARKERS; HUMANS; MYOCARDIAL INFARCTION; POLYMORPHISM, GENETIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 63049104395     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000210188     Document Type: Note

References (20)

1. Lindahl B, Toss H, Siegbahn A, Venge P, Wallentin L: Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease: FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. N Engl J Med 2000;343:1139-1147.
2. Lee SH, Wolf PL, Escudero R, Deutsch R, Jamieson SW, Thistlethwaite PA: Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N Engl J Med 2000;342:626-633.
3. Lee KW, Lip GY, Blann AD: Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2, and vascular endothelial grow th factor levels in acute coronary syndromes. Circulation 2004;110:2355-2360.
4. Ogawa H, Suefuji H, Soejima H, Nishiyama K, Misumi K, Takazoe K, Miyamoto S, Kajiwara I, Sumida H, Sakamoto T, Yoshimura M, Kugiyama K, Yasue H, Matsuo K: Increased blood vascular endothelial growth factor levels in patients with acute myocardial infarction. Cardiology 2000;93:93-99.
5. Heeschen C, Dimmeler S, Hamm CW, Boersma E, Zeiher AM, Simoons ML;CAPTURE (c7E3 Anti-Platelet Therapy in Unstable Refractory Angina) investigators: Prognostic significance of angiogenic growth factor serum levels in patients with acute coronary syndromes. Circulation 2003;107:524-530.
6. Marfella R, Esposito K, Nappo F, Siniscalchi M, Sasso FC, Portoghese M, Di Marino MP, Baldi A, Cuzzocrea S, Di Filippo C, Barboso G, Baldi F, Rossi F, DAmico M, Giugliano D: Expression of angiogenic factors during acute coronary syndromes in human type 2 diabetes. Diabetes 2004;53:2383-2391.
7. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z: Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 1999;13: 9-22.
8. Brogan IJ, Khan N, Isaac K, Hutchinson JA, Pravica V, Hutchinson IV: Novel polymorphisms in the promoter and 5′ UTR regions of the human vascular endothelial growth factor gene. Hum Immunol 1999;60:1245-1249.
9. Simari RD, O'Brien T: Clinical trials in vascular gene therapy: the missing piece of the puzzle. Arch Pathol Lab Med 2002;126:317-319.
10. Weigand MA, Hörner C, Bardenheuer HJ, Bouchon A: The systemic inflammatory response syndrome. Best Pract Res Clin Anaesthesiol 2004;18:455-475.
11. Denizot Y, Guglielmi L, Cornu E, Nathan N: Alterations in plasma angiogenic growth factor concentrations after coronary artery bypass graft surgery: relationships with post-operative complications. Cytokine 2003;24:7-12.
12. Denizot Y, Leguyader A, Cornu E, Laskar M, Orsel I, Vincent C, Nathan N: Alterations in plasma soluble vascular endothelial growth factor receptor-1 (sFlt-1) concentrations during coronary artery bypass graft surgery: relationships with post-operative complications. Cardiothorac Surg 2008;3:16.
13. Awata T, Inoue K, Kurihara S, Watanabe M, Inukai K, Inoue I, Katayama S: A common polymorphism in the 5′-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes 2002;51: 1635-1639.
14. Duh E, Aiello LP: Vascular endothelial growth factor and diabetes: the agonist versus antagonist paradox. Diabetes 1999;48: 1899-1906.
15. Inoue M, Itoh H, Ueda M, et al: Vascular endothelial growth factor expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis. Circulation 1998;98:2108-2116.
16. Petrovic D, Verhovec R, Globocnik Petrovic M, Osredkar J, Peterlin B: Association of vascular endothelial growth factor gene polymorphism with myocardial in farction in patients with type 2 diabetes. Cardiology 2007;107:291-295.
17. Van der Meer P, De Boer RA, White HL, van der Steege G, Hall AS, Voors AA, van Veldhuisen DJ: The VEGF +405 CC promoter polymorphism is associated with an impaired prognosis in patients with chronic heart failure: a MERIT-HF substudy. J Card Fail 2005;11:279-284.
18. Petrovic MG, Korosec P, Kosnik M, Osredkar J, Hawlina M, Peterlin B, Petrovic D: Local and genetic determinants of vascular endothelial growth factor expression in advanced proliferative diabetic retinopathy. Mol Vis 2008;14:1382-1387.
19. Ray D, Mishra M, Ralph S, Read I, Davies R, Brenchley P: Association of the VEGF gene with proliferative diabetic retinopathy but not proteinuria in diabetes. Diabetes 2004;53:861-864.
20. Douvaras P, Antonatos DG, Kekou K, Patsilinakos S, Chouliaras G, Christou A, Andrikou A, Kanavakis E: Association of VEGF gene polymorphisms with the development of heart failure in patients after myocardial infarction. Cardiology 2009;114:11-18.